Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LNZ100 and LNZ101 for Presbyopia (China Phase 3)
NCT06045299Phase 3Completed
- Sponsor
- CORXEL Pharmaceuticals
- Start
- Sep 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aceclidine in presbyopia, sponsored by CORXEL Pharmaceuticals. Started Sep 2023; status: completed.
02
Drugs
aceclidine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT06045299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06045299.